药物引起的肝损伤. 第二部分:晚期并发症和肝毒性监测
Dorota M Kozielewicz1,2, Piotr Stalke3
1Department of Infectious Diseases and Hepatology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.
Clinical and experimental hepatology
|September 4, 2025
概括
药物诱导的肝损伤 (DILI) 可以导致慢性肝病,包括纤维化和自身免疫性肝炎. 与DILI相关的长期结果和死亡风险尚不清楚,需要进一步调查.
科学领域:
- 肝病学
- 毒理学
- 免疫学
背景情况:
- 药物诱导性肝损伤 (DILI) 具有不同的临床表现和预后.
- 虽然大多数DILI病例是急性,但在药物停用后6-12个月内,慢性肝病可能发生在3. 4%~39. 0%的病例中.
- 与慢性DILI相关的长期发病率和死亡率尚不清楚.
研究的目的:
- 阐明药物诱导性肝损伤的多态性.
- 审查DILI后可能出现的慢性肝病的范围.
- 突出特定DILI表现的预后影响,例如阻塞性胆道综合征.
主要方法:
- 关于DILI的文献审查和现有数据的综合.
- 在药物暴露后报告的慢性肝病例的分析.
- 对DILI的长期后果和预后因素的研究.
主要成果:
- DILI表现出多态的临床图景,结果各不相同.
- 慢性肝病,包括纤维化,自身免疫性肝炎和肉脂性肝炎,可以在DILI后发展.
- 阻塞性胆道综合征是一种罕见但严重的并发症,预后不佳,包括肝衰竭和移植需要.
- 免疫检查点抑制剂可以诱导T细胞透的硬化性胆管炎.
结论:
- DILI的长期后果是多样化的,可以显著影响患者的发病率和死亡率.
- 早期识别和治疗DILI对于减轻慢性肝病的风险至关重要.
- 需要进一步的研究来充分了解DILI的慢性后果,并优化治疗策略.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Esophageal Varices-II: Clinical Features and Management
133
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
133
Acute Kidney Injury III: Clinical Manifestations
86
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
86
Nonlinear Pharmacokinetics: Overview
541
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
541
Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
Hepatic Drug Excretion: Influencing Factors
214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214


